Cepheid
Peter Farrell serves as the Executive Vice President at Cepheid, where responsibilities encompass global commercial operations for the leading molecular diagnostic company since June 2014. Prior to this role, Farrell held various positions at Abbott, ultimately becoming Divisional Vice President and General Manager for Abbott Point of Care, overseeing worldwide commercial operations for a $400 million business. Peter's earlier experience includes serving as Executive Vice President at iCAD Inc. and CADx, where strategic planning for worldwide operations was key, and as National Sales Manager for Abbott Diagnostics in Canada. Farrell's career began in sales at Rhone Poulenc Pharma and as a researcher at the Hamilton Regional Virology Laboratory. Educationally, Farrell holds a Bachelor of Applied Science in Virology from Western University.
This person is not in any teams
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.